ZICIX misses Form 10-K deadline due to staffing
ZICIX Corporation notified the SEC that it cannot timely file its Annual Report on Form 10-K for the period ended March 31, 2026 due to continued staffing shortages and will file on or before the fifteenth calendar day following the prescribed due date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ZICIX Corporation notified the SEC that it cannot timely file its Annual Report on Form 10-K for the period ended March 31, 2026 due to continued staffing shortages and will file on or before the fifteenth calendar day following the prescribed due date.
The company reported net revenues of $749,373 for the year ended March 31, 2026 versus $70,068 for the year ended March 31, 2025. Operating expenses were $836,133 for 2026 and $864,406 for 2025. The company recorded a goodwill impairment of $1,376,083 in 2025. Net loss was approximately $551,067 for 2026 and $3,294,418 for 2025.
Insights
Late-filing notice cites staffing shortages; filer commits to 15-day cure.
The notification states the registrant cannot complete its Form 10-K for the period ended March 31, 2026 without "unreasonable effort and expense" due to "continued staffing shortages." The company expressly states it "will file on or before the fifteenth calendar day following the prescribed due date."
Regulatory risk is procedural: exchanges or the SEC may review repeated late filings. Subsequent disclosures should show whether staffing constraints are resolved; the filing itself sets the operative cure deadline.
Reported 2026 revenue growth from $70k to $749k but net loss persists due to costs and a prior goodwill impairment.
Revenue for year ended March 31, 2026 is shown as $749,373 versus $70,068 a year earlier. Operating expenses were $836,133 in 2026. A goodwill impairment of $1,376,083 was recorded in 2025 and materially widened prior-year net loss.
Materiality: the 2026 net loss of $551,067 is presented alongside the prior-year loss of $3,294,418. Further detail will appear in the delayed Form 10-K.
Key Figures
Key Terms
Rule 12b-25 regulatory
goodwill impairment financial
fifteenth calendar day cure regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.